Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Emmaus Life Sciences, Inc. (EMMA) had Free Cash Flow per Share of $0.01 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$6.32M |
|
$1.34M |
|
$0.34M |
|
$5.97M |
|
$2.53M |
|
$3.79M |
|
$-2.45M |
|
$1.34M |
|
$2.07M |
|
$1.34M |
|
$1.34M |
|
$1.34M |
|
$2.07M |
|
$3.79M |
|
$3.92M |
|
70.19M |
|
120.54M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$6.00M |
|
$0.09M |
|
$10.37M |
|
$16.37M |
|
$66.12M |
|
$2.25M |
|
$16.43M |
|
$82.55M |
|
$-66.18M |
|
$-66.18M |
|
$-66.18M |
|
70.19M |
|
| Cash Flow Statement Financials | |
$1.35M |
|
$1.58M |
|
$-2.24M |
|
$2.13M |
|
$2.81M |
|
$0.68M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.09 |
|
-- |
|
-- |
|
-0.04 |
|
-0.44 |
|
94.56% |
|
60.00% |
|
60.00% |
|
-- |
|
21.18% |
|
21.19% |
|
$1.35M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
0.22 |
|
8.91 |
|
10.10 |
|
-2.02% |
|
-2.02% |
|
8.18% |
|
-2.09% |
|
$-0.94 |
|
|
Free Cash Flow per Share |
$0.01 |
$0.01 |
|